# UBASH3A

## Overview
UBASH3A is a gene located on chromosome 21q22.3 that encodes the protein ubiquitin associated and SH3 domain containing A, which is primarily expressed in T-cells. This protein is characterized by its unique domain architecture, including an N-terminal ubiquitin-binding domain (UBA), a central Src homology 3 (SH3) domain, and a C-terminal histidine phosphatase domain. Functionally, UBASH3A acts as a negative regulator of T-cell receptor (TCR) signaling, playing a crucial role in immune homeostasis by modulating the synthesis and dynamics of TCR-CD3 complexes. It is involved in the ubiquitin-proteasome system and endoplasmic-reticulum-associated protein degradation (ERAD) pathway, influencing protein quality control and immune cell signaling. UBASH3A's interactions with various proteins, such as spleen tyrosine kinase (Syk) and E3 ubiquitin ligases, underscore its importance in cellular signaling and immune regulation. Dysregulation of UBASH3A is associated with autoimmune diseases, including type 1 diabetes and systemic lupus erythematosus, highlighting its clinical significance (Vukojević2024The; Ge2019UBASH3A; Newman2023UBASH3A).

## Structure
UBASH3A is a protein encoded by the UBASH3A gene, located on chromosome 21q22.3. The protein is 661 amino acids long and has a molecular mass of 74,123 Daltons (Vukojević2024The; Wattenhofer2001Isolation). It features a unique domain architecture comprising an N-terminal ubiquitin-binding domain (UBA), a centrally located Src homology 3 (SH3) domain, and a C-terminal histidine phosphatase domain, also known as a phosphoglycerate mutase-like domain (Vukojević2024The; Wattenhofer2001Isolation). The UBA domain, spanning amino acids 20-60, binds to monoubiquitin and ubiquitylated proteins, while the SH3 domain, located between amino acids 280-335, facilitates protein-protein interactions (Wattenhofer2001Isolation). The histidine phosphatase domain, found between amino acids 400-511, is involved in hydrolyzing low-molecular-weight phosphatase substrates, particularly proteins containing phosphotyrosine (Vukojević2024The; Wattenhofer2001Isolation).

UBASH3A is expressed primarily in T-cells and is localized in the nucleoplasm and Golgi apparatus (Vukojević2024The). It has three isoforms produced by alternative splicing (Vukojević2024The). The protein's oligomerization, mediated by the domain closest to the C-terminal end, remains unclear (Vukojević2024The). Post-translational modifications may include phosphorylation, although specific details are not provided in the context.

## Function
The UBASH3A gene encodes a protein that plays a critical role in regulating T-cell receptor (TCR) signaling, which is essential for maintaining immune homeostasis. In healthy human cells, UBASH3A functions as a negative regulator of T-cell activation by modulating the synthesis and dynamics of TCR-CD3 complexes. It interacts with multiple components of the TCR-CD3 complex, including CD3ε and CD3ζ, and facilitates the internalization and degradation of these complexes upon TCR engagement, thereby reducing their presence on the cell surface (Ge2019UBASH3A).

UBASH3A also plays a role in the ubiquitin-proteasome system by binding to ubiquitin chains and interacting with proteins involved in endocytic recycling and protein degradation pathways. It is involved in the endoplasmic-reticulum-associated protein degradation (ERAD) pathway, which is crucial for protein quality control (Ge2019UBASH3A). The protein is primarily active in the cytoplasm and nucleoplasm of T-cells, where it modulates immune cell signaling by influencing the activation thresholds of TCRs (Vukojević2024The).

UBASH3A's regulatory effects are largely phosphatase-independent, relying on its ubiquitin-associated (UBA) and Src homology 3 (SH3) domains to interact with other proteins and modulate signaling pathways (Vukojević2024The). This regulation is crucial for preventing excessive T-cell responses and maintaining immune tolerance, with dysregulation potentially contributing to autoimmune diseases (Vukojević2024The).

## Clinical Significance
Mutations and alterations in the UBASH3A gene are associated with several autoimmune diseases. In type 1 diabetes (T1D), specific single nucleotide polymorphisms (SNPs) such as rs11203203 and rs80054410 are linked to increased UBASH3A expression and decreased IL2 expression in CD4+ T cells, contributing to disease risk by inhibiting NF-κB signaling (Ge2017UBASH3A; Newman2023UBASH3A). The minor allele of rs1893592, however, is protective against T1D, as it reduces UBASH3A mRNA levels and increases IL-2 secretion, highlighting its role in modulating immune responses (Ge2018Moleculargenetic).

UBASH3A is also implicated in systemic lupus erythematosus (SLE), with polymorphisms such as rs9976767 and rs2277798 showing significant associations with the disease in certain populations (Liu2015Association; DiazGallo2013Evidence). In rheumatoid arthritis (RA), UBASH3A is downregulated in CD4+ T cells, leading to excessive TCR signaling and increased IL-6 production, a pro-inflammatory cytokine involved in RA pathogenesis (Yamagata2022IL6). These findings underscore the clinical significance of UBASH3A in autoimmune diseases, where its expression and genetic variations influence disease susceptibility and progression.

## Interactions
UBASH3A interacts with several proteins, playing a significant role in immune regulation and cellular signaling. It is known to interact with spleen tyrosine kinase (Syk), influencing B-cell receptor signaling and regulating Syk activity (Vukojević2024The). UBASH3A also binds to CBL and CBL-B, E3 ubiquitin ligases, through its SH3 domain, which is crucial for modulating T-cell receptor (TCR) signaling and inhibiting T-cell function (Ge2019UBASH3A; Newman2023UBASH3A). This interaction is important for the downmodulation of TCR-CD3 complexes upon TCR engagement (Ge2019UBASH3A).

UBASH3A interacts with PTPN22, a non-receptor tyrosine phosphatase, in T cells. This interaction, mediated by the SH3 domain of UBASH3A, affects IL2 expression and is implicated in the risk for type 1 diabetes (Newman2023UBASH3A). The interaction between UBASH3A and PTPN22 is not affected by the T1D risk variant rs2476601 in PTPN22 (Newman2023UBASH3A).

UBASH3A also interacts with apoptosis-inducing factor (AIF), facilitating caspase-independent apoptosis in T-cells during growth factor withdrawal (Vukojević2024The). These interactions highlight UBASH3A's role in modulating immune responses and cellular homeostasis.


## References


[1. (Liu2015Association) Jie Liu, Juan Liu, Jing Ni, Rui Xue Leng, Hai Feng Pan, and Dong Qing Ye. Association of ubash3a gene polymorphisms and systemic lupus erythematosus in a chinese population. Gene, 565(1):116–121, July 2015. URL: http://dx.doi.org/10.1016/j.gene.2015.04.005, doi:10.1016/j.gene.2015.04.005. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2015.04.005)

[2. (Ge2018Moleculargenetic) Yan Ge and Patrick Concannon. Molecular-genetic characterization of common, noncoding ubash3a variants associated with type 1 diabetes. European Journal of Human Genetics, 26(7):1060–1064, February 2018. URL: http://dx.doi.org/10.1038/s41431-018-0123-5, doi:10.1038/s41431-018-0123-5. This article has 20 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41431-018-0123-5)

[3. (DiazGallo2013Evidence) Lina-Marcela Diaz-Gallo, Elena Sánchez, Norberto Ortego-Centeno, Jose Mario Sabio, Francisco J. García-Hernández, Enrique de Ramón, Miguel A. González-Gay, Torsten Witte, Hans-Joachim Anders, María F. González-Escribano, and Javier Martin. Evidence of new risk genetic factor to systemic lupus erythematosus: the ubash3a gene. PLoS ONE, 8(4):e60646, April 2013. URL: http://dx.doi.org/10.1371/journal.pone.0060646, doi:10.1371/journal.pone.0060646. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0060646)

[4. (Yamagata2022IL6) Kaoru Yamagata, Shingo Nakayamada, Tong Zhang, Anh Phuong Nguyen, Naoaki Ohkubo, Shigeru Iwata, Shigeaki Kato, and Yoshiya Tanaka. Il-6 production through repression of ubash3a gene via epigenetic dysregulation of super-enhancer in cd4+ t cells in rheumatoid arthritis. Inflammation and Regeneration, November 2022. URL: http://dx.doi.org/10.1186/s41232-022-00231-9, doi:10.1186/s41232-022-00231-9. This article has 4 citations.](https://doi.org/10.1186/s41232-022-00231-9)

[5. (Ge2019UBASH3A) Yan Ge, Taylor K. Paisie, Sixue Chen, and Patrick Concannon. Ubash3a regulates the synthesis and dynamics of tcr–cd3 complexes. The Journal of Immunology, 203(11):2827–2836, December 2019. URL: http://dx.doi.org/10.4049/jimmunol.1801338, doi:10.4049/jimmunol.1801338. This article has 36 citations.](https://doi.org/10.4049/jimmunol.1801338)

[6. (Vukojević2024The) Katarina Vukojević, Violeta Šoljić, Vlatka Martinović, Fila Raguž, and Natalija Filipović. The ubiquitin-associated and sh3 domain-containing proteins (ubash3) family in mammalian development and immune response. International Journal of Molecular Sciences, 25(3):1932, February 2024. URL: http://dx.doi.org/10.3390/ijms25031932, doi:10.3390/ijms25031932. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms25031932)

[7. (Wattenhofer2001Isolation) Marie Wattenhofer, Kazunori Shibuya, Jun Kudoh, Robert Lyle, Joelle Michaud, Colette Rossier, Kazuhiko Kawasaki, Shuichi Asakawa, Shinsei Minoshima, Asher Berry, Batsheva Bonne-Tamir, Nobuyoshi Shimizu, Stylianos Antonarakis, and Hamish Scott. Isolation and characterization of the ubash3a gene on 21q22.3 encoding a potential nuclear protein with a novel combination of domains. Human Genetics, 108(2):140–147, March 2001. URL: http://dx.doi.org/10.1007/s004390000453, doi:10.1007/s004390000453. This article has 43 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s004390000453)

[8. (Ge2017UBASH3A) Yan Ge, Taylor K. Paisie, Jeremy R.B. Newman, Lauren M. McIntyre, and Patrick Concannon. Ubash3a mediates risk for type 1 diabetes through inhibition of t-cell receptor–induced nf-κb signaling. Diabetes, 66(7):2033–2043, June 2017. URL: http://dx.doi.org/10.2337/db16-1023, doi:10.2337/db16-1023. This article has 45 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.2337/db16-1023)

[9. (Newman2023UBASH3A) Jeremy R. B. Newman, Patrick Concannon, and Yan Ge. Ubash3a interacts with ptpn22 to regulate il2 expression and risk for type 1 diabetes. International Journal of Molecular Sciences, 24(10):8671, May 2023. URL: http://dx.doi.org/10.3390/ijms24108671, doi:10.3390/ijms24108671. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms24108671)